secwatch / observer
8-K filed May 23, 2025, 7:59 PM ET ticker HYPR CIK 0001833769
leadership confidence high sentiment neutral materiality 0.40

Hyperfine Chairperson Huennekens resigns; Wolterman appointed as Chair

Hyperfine, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

R. Scott Huennekens

Chairperson
HYPR · Hyperfine, Inc.
Effective
2025-05-22
Successor
Daniel J. Wolterman
Filed
May 23, 2025, 7:59 PM ET
R. Scott Huennekens, Chairperson of the Board of Directors (the “Board”) of Hyperfine, Inc. (the “Company”), notified the Company of his decision to resign as Chairperson and member of the Board, effective as of May 22, 2025
Appointed

Daniel J. Wolterman

Chairperson
HYPR · Hyperfine, Inc.
Effective
2025-05-22
Filed
May 23, 2025, 7:59 PM ET
the Board appointed Daniel J. Wolterman, a current member of the Board, as Chairperson of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

R. Scott Huennekens resigned as Chairperson at Hyperfine, Inc..

Action
resigned
Role
Chairperson
Exact text from the filing
R. Scott Huennekens, Chairperson of the Board of Directors (the “Board”) of Hyperfine, Inc. (the “Company”), notified the Company of his decision to resign as Chairperson and member of the Board, effective as of May 22, 2025
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Daniel J. Wolterman was appointed as Chairperson at Hyperfine, Inc..

Action
appointed
Role
Chairperson
Exact text from the filing
the Board appointed Daniel J. Wolterman, a current member of the Board, as Chairperson of the Board.
View on SEC.gov

Hyperfine, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-25-125906
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.